USPTO Examiner SAWYER JENNIFER C - Art Unit 1691

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18860494PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOPHENOL DERIVATIVESOctober 2024February 2025Allow400NoNo
18438965ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROMFebruary 2024April 2025Allow1400YesNo
18435857DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORSFebruary 2024February 2025Allow1300NoNo
18428938PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATEJanuary 2024June 2025Allow1611NoNo
18566281METHOD FOR OBTAINING BIO-SOURCED N-VINYLFORMAMIDEDecember 2023December 2024Allow1210YesNo
18498102NON-PEPTIDIC CELL-PENETRATING MOTIFSOctober 2023March 2025Allow1611YesNo
18476222LONG CHAIN ALKYL ESTERAMINE LIPID COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN NUCLEIC ACID DELIVERYSeptember 2023March 2025Allow1721YesNo
18233769Carbondisulfide Derived ZwitterionsAugust 2023September 2024Allow1311YesNo
18176862PROCESS OF MAKING A CRYSTALLINE EDG-2 RECEPTOR ANTAGONISTMarch 2023April 2025Allow2502YesNo
18102727SYNTHESIS OF (R)(+)-2-(4-CHLORO-2-METHYL PHENOXY)PROPANOIC ACID IN HIGH ENANTIOMERIC EXCESSJanuary 2023November 2024Allow2220YesNo
18004261METHOD FOR PRODUCING AROMATIC AMINOMETHYLJanuary 2023February 2025Allow2500NoNo
17998738CO-PRODUCTION OF MONOMERS, INCLUDING AT LEAST ONE BIO-BASED MONOMERNovember 2022January 2025Allow2600NoNo
17913175PROCESS FOR THE PREPARATION OF HEXAMETHYLENEDIAMINE BY HYDROGENATION OF ADIPONITRILE WITH REDUCED FORMATION OF DIAMINOCYCLOHEXANESeptember 2022May 2025Allow3200YesNo
17906603MEMBRANE SEPARATION PROCESS FOR SEPARATING CARBONATE-CONTAINING DIAMINOALKANE SOLUTIONSeptember 2022July 2025Allow3400YesNo
17941017Spacered Urea (Meth)AcrylatesSeptember 2022April 2025Allow3131YesNo
17783280SEPARATION OF N-METHYLETHYLENEDIAMINE FROM EDA-CONTAINING MIXTURESJune 2022April 2025Allow3500YesNo
17781405PROCESS FOR THE PURIFICATION OF A MIXTURE COMPRISING N-ALKYL-HYDROXYLAMMONIUM SALTSJune 2022May 2025Allow3500YesNo
17766615PRODUCTION OF AROMATIC ACIDS AND PHENOLICSApril 2022April 2025Allow3700YesNo
17754104METHOD FOR PREPARING FORMAMIDE COMPOUNDS VIA HYDROGENATION OF CARBON DIOXIDE CATALYZED BY POROUS MATERIALSMarch 2022March 2025Allow3600YesNo
17626648PROCESS FOR THE PREPARATION OF A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV)January 2022March 2025Allow3800NoNo
17617503GAS-PHASE PROCESS FOR THE CONVERSION OF GLYCOLALDEHYDE WITH AN AMINATING AGENTDecember 2021June 2025Allow4210YesNo
17609868PROCESS FOR THE SYNTHESIS OF THE IONIC LIQUID TETRAOCTYLAMMONIUM DI(2-ETHYLHEXYL)-OXAMATE (IL-5), PRODUCT OBTAINED AND ITS USE IN SELECTIVE METAL EXTRACTIONNovember 2021May 2025Abandon4301NoNo
17607656AMINE-INITIATED POLYOLS AS NON-EMISSIVE CATALYSTS IN HR FOAMOctober 2021April 2025Abandon4101NoNo
17603019PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVESOctober 2021January 2025Allow3901YesNo
17477666STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOFSeptember 2021April 2025Abandon4321YesNo
17424454METHOD FOR PREPARING SODIUM TAURATE AS TAURINE INTERMEDIATE, AND METHOD FOR PREPARING TAURINEJuly 2021January 2025Allow4101YesNo
17423247USE OF N-BENZYLBENZAMIDE-BASED COMPOUND AS HERBICIDEJuly 2021June 2025Abandon4720NoNo
17293838ISOTOPE LABELING FOR UNIVERSAL MULTIPLEXING OF METABOLITESMay 2021May 2025Abandon4821NoNo
16613049CLASS A GPCR-BINDING COMPOUND MODIFIERNovember 2019February 2025Allow6042YesNo
15852922AMINE SALTS OF A PROSTACYCLIN ANALOGDecember 2017August 2018Allow800NoNo
13069239FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATIONMarch 2011February 2013Allow2311YesNo
13048644PROCESS FOR PRODUCTION OF TEREPHTHALIC ACIDMarch 2011April 2012Allow1310NoNo
13048537PROCESS FOR PRODUCTION OF ISOPHTHALIC ACIDMarch 2011April 2012Allow1310NoNo
13035637FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATIONFebruary 2011July 2012Allow1711YesNo
12922285NOVEL DIAMANTANE COMPOUNDS, LIQUID CRYSTALLINE COMPOUNDS, AND LIQUID CRYSTALLINE COMPOSITIONSOctober 2010August 2013Allow3511YesNo
12810300Process for the Synthesis of Propargylated Aminoindan DerivativesSeptember 2010February 2013Allow3201NoNo
12920224METAL CARBAMATES FORMED FROM TOLYLENEDIAMINESAugust 2010March 2013Allow3011NoNo
12918931METAL CARBAMATES FORMED FROM DIAMINOPHENYLMETHANEAugust 2010April 2013Allow3211YesNo
12746469METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAMEAugust 2010December 2012Allow3001NoNo
12599624NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICSJune 2010January 2012Allow2611NoNo
12739606Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The SameApril 2010December 2012Allow3201NoNo
11921972PRODUCTION OF N-ARYL CARBAMATES AND N-ARYL ISOCYANATESApril 2010July 2011Allow4310NoNo
12680852METHODS FOR THE SYNTHESIS OF ORGANIC SULFIDES BY USING SULFIDES AND ORGANIC SULFUR-INDIUM COMPLEXESMarch 2010February 2013Allow3511NoNo
12750336PHENYL-SUBSTITUTED BICYCLOOCTANE-1,3-DIONE DERIVATIVESMarch 2010August 2012Allow2901NoNo
12678698UV ABSORBING COMPOUNDSMarch 2010July 2012Allow2801YesNo
12678612COMPOUNDS ISOLATED FROM ANTRODIA CINNAMOMEA AND USE THEREOFMarch 2010September 2011Allow1810NoNo
12733711N,N-DIMETHYL IMIDODICARBONIMIDIC DIAMIDE DICARBOXYLATE, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAMEMarch 2010September 2011Allow1811NoNo
12672416SALTS OF TRAMADOL AND NAPROXEN AND THEIR CRYSTAL FORMS IN THE TREATMENT OF PAINMarch 2010February 2012Allow2421NoNo
12733479AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELSMarch 2010September 2013Allow4321YesNo
12530007INSECTICIDAL COMPOUNDSJanuary 2010April 2012Allow3221NoYes
12670294IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROLJanuary 2010August 2012Allow3101YesNo
12651268PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS AND COMPOSITIONSDecember 2009September 2013Allow4521YesNo
12651142PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERSDecember 2009April 2013Allow3921YesNo
12592318MULTIFUNCTIONAL ANIONIC SURFACTANTSNovember 2009November 2010Allow1200NoNo
12448672METHOD FOR PREPARATION OF 6-[3-(1-ADAMANTYL) -4-METHOXYPHENYL]-2-NAPHTOIC ACIDOctober 2009October 2011Allow2720NoYes
12603025COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERSOctober 2009October 2013Allow4822YesNo
125307774-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDESOctober 2009August 2012Allow3511NoNo
12563366POLYCYCLIC PENTAFLUOROSULFANYLBENZENE COMPOUND AND PROCESS FOR PRODUCING THE COMPOUNDSeptember 2009June 2011Allow2111NoNo
12531972METHOD FOR THE SYNTHESIS OF PEPTIDES WITHOUT SOLVENTSeptember 2009March 2011Allow1710NoNo
12304415METHOD OF REPLACING DISPERSION MEDIUMSeptember 2009April 2012Allow4010NoNo
12448386PROCESS FOR PREPARING AROMATIC POLYCARBOXYLIC ACID BY LIQUID PHASE OXIDATIONSeptember 2009April 2011Allow2210NoNo
12461153Method for making hindered phenolic antioxidantAugust 2009December 2013Allow5230NoNo
12520450PRODUCTS FOR THE TREATMENT OF THE IRON CHLOROSISJune 2009February 2011Allow2001YesNo
12476978APPARATUS AND METHOD FOR CARRYING OUT MULTIPLE REACTIONSJune 2009March 2012Allow3321YesNo
12446460PROCESS FOR PREPARING ISOCYANATESMay 2009March 2012Allow3420YesNo
12445259NOVEL BIS(FORMYLPHENYL)ALKANE AND NOVEL POLYNUCLEAR PHENOL DERIVED FROM THE SAMEMay 2009October 2010Allow1900NoNo
12513864METHOD FOR THE PRODUCTION OF ISOCYANATESMay 2009January 2012Allow3230YesNo
12376803METHOD FOR PRODUCING OPTICALLY ACTIVE HYDROXYCARBOXYLIC ACID DERIVATIVES OR SALTS THEREOFApril 2009August 2011Allow3010NoNo
12438086METHOD FOR PRODUCING ISOCYANATESFebruary 2009February 2012Allow3511NoNo
12281819PREPARATION OF CHIRAL AMIDES AND AMINESJanuary 2009August 2011Allow3611NoNo
12374835METHOD OF REPLACING DISPERSION MEDIUMJanuary 2009April 2012Allow3910NoNo
12306980PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATESJanuary 2009July 2013Allow5521YesNo
12306675SITE-SPECIFIC INHIBITORS OF HISTONE METHYLTRANSFERASE [HMTASE] AND PROCESS OF PREPARATION THEREOFDecember 2008November 2010Allow2200NoNo
12331627AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTSDecember 2008October 2011Allow3410NoNo
123316593-CARBOXYPROPYL-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTSDecember 2008September 2011Allow3410NoNo
12303829SYNTHESIS OF PHENOLIC ESTERS OF HYDROXYMETHYL PHENOLSDecember 2008March 2011Allow2700NoNo
121599672,4,6-TRIALKYLPHENYL SUBSTITUTED CYCLOPENTANE-1,3-DIONENovember 2008February 2012Allow4311NoNo
12281294FULLERENE DERIVATIVESOctober 2008January 2012Allow4021NoNo
12253264CARBON LINKED MODULATORS OF GAMMA-SECRETASEOctober 2008November 2013Allow6041NoNo
12005226CERAMIDE DERIVATIVES, METHOD FOR PREPARING THE SAME, AND THERAPEUTIC AGENT FOR TREATING ATOPIC DERMATITIS COMPRISING THE CERAMIDE DERIVATIVESDecember 2007October 2008Allow900NoNo
11923093INTERMEDIATES IN PRODUCING PHENOXYACETIC ACID DERIVATIVES AND METHOD OF USING THE SAMEOctober 2007March 2008Allow500NoNo
11905910STATIN DERIVATIVESOctober 2007September 2008Allow1200NoNo
11905893STATIN DERIVATIVESOctober 2007August 2008Allow1001NoNo
11693510MICHAEL-ADDUCT FLUOROCHEMICAL SILANESMarch 2007September 2007Allow600NoNo
11657534METHOD FOR PRODUCTION OF METHIONINE FROM HOMOSERINEJanuary 2007December 2007Allow1101NoNo
11614695PARTIAL OXIDATION USING MOLECULAR SIEVE SSZ-74December 2006May 2008Allow1710NoNo
11614701ACYLATION USING MOLECULAR SIEVE SSZ-74December 2006October 2008Allow2220NoNo
11634735PROCESS FOR THE FLUORINATION OF BORON HYDRIDESDecember 2006June 2008Allow1800YesNo
11590770STATIN DERIVATIVESNovember 2006July 2007Allow901NoNo
10554742SILANYL-N-ALKANAL COMPOUNDS, METHOD FOR PRODUCTION AND USE THEREOFOctober 2006July 2008Allow3201NoNo
11528490BISPHENOL COMPOUND AND PROCESS FOR PREPARATION THEREOFSeptember 2006December 2007Allow1510NoNo
10591698PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROCHEMICALSeptember 2006September 2007Allow1200NoNo
10558495POLYHYDROXY PHENOLS AND THEIR USE IN BINDING P-SELECTINJuly 2006May 2007Allow1800NoNo
11484991PROCESS FOR THE DIASTEREOSELECTIVE ALKYLATION OF AN ETHER OXIME OF THE COMPOUND NOPINONE AND NOVEL INTERMEDIATES FOR THE SYNTHESIS OF DIASTEREOSPECIFIC 2-AMINO-NOPINONE DERIVATIVES SUBSTITUTED ON CARBON 3July 2006February 2008Allow1901NoNo
10577070METHOD FOR THE PRODUCTION OF 6,6,6-TRIHALO-3,5-DIOXOHEXANOIC ACID ESTERSJune 2006October 2007Allow1810NoNo
11448127BIOMIMETIC SYSTEMS CONSISTING OF LIPID MEMBRANES BOUND TO AN ELECTRICALLY CONDUCTING SUBSTRATEJune 2006June 2008Allow2410NoNo
11431944OXIDATION OF ALKANESMay 2006August 2007Allow1510NoNo
11392909PROCESS FOR THE PREPARATION OF ADAPALENEMarch 2006October 2007Allow1910NoNo
11390777DIIMINES AND SECONDARY DIAMINESMarch 2006May 2007Allow1410NoNo
11388816METHOD FOR REDUCING MICROCONTAMINANTS DURING SYNTHESIS OF PENTACHLOROPHENOLMarch 2006June 2008Allow2730NoYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SAWYER, JENNIFER C.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
3
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
95.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner SAWYER, JENNIFER C - Prosecution Strategy Guide

Executive Summary

Examiner SAWYER, JENNIFER C works in Art Unit 1691 and has examined 100 patent applications in our dataset. With an allowance rate of 95.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner SAWYER, JENNIFER C's allowance rate of 95.0% places them in the 86% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SAWYER, JENNIFER C receive 0.94 office actions before reaching final disposition. This places the examiner in the 10% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SAWYER, JENNIFER C is 30 months. This places the examiner in the 39% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +3.5% benefit to allowance rate for applications examined by SAWYER, JENNIFER C. This interview benefit is in the 24% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 45.8% of applications are subsequently allowed. This success rate is in the 96% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 37.5% of cases where such amendments are filed. This entry rate is in the 49% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 86% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 16.7% are granted (fully or in part). This grant rate is in the 8% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 24.0% of allowed cases (in the 99% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.1% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.